PL3351267T3 - Szczepionka ochronna przeciwko lawsonia intracellularis - Google Patents

Szczepionka ochronna przeciwko lawsonia intracellularis

Info

Publication number
PL3351267T3
PL3351267T3 PL18154850T PL18154850T PL3351267T3 PL 3351267 T3 PL3351267 T3 PL 3351267T3 PL 18154850 T PL18154850 T PL 18154850T PL 18154850 T PL18154850 T PL 18154850T PL 3351267 T3 PL3351267 T3 PL 3351267T3
Authority
PL
Poland
Prior art keywords
vaccine
protection against
lawsonia intracellularis
against lawsonia
intracellularis
Prior art date
Application number
PL18154850T
Other languages
English (en)
Inventor
Antonius Arnoldus Christiaan Jacobs
Paul Vermeij
Ruud Philip Antoon Maria Segers
Carla Christina Schrier
Original Assignee
Intervet International B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41212183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3351267(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet International B.V. filed Critical Intervet International B.V.
Publication of PL3351267T3 publication Critical patent/PL3351267T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL18154850T 2008-04-18 2009-04-16 Szczepionka ochronna przeciwko lawsonia intracellularis PL3351267T3 (pl)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US4616108P 2008-04-18 2008-04-18
EP08154764 2008-04-18
US11175608P 2008-11-06 2008-11-06
EP08105738 2008-11-06
EP09753743.5A EP2268308B2 (en) 2008-04-18 2009-04-16 Vaccine for protection against lawsonia intracellulars
EP18154850.4A EP3351267B1 (en) 2008-04-18 2009-04-16 Vaccine for protection against lawsonia intracellularis
PCT/EP2009/054516 WO2009144088A2 (en) 2008-04-18 2009-04-16 Vaccine for protection against lawsonia intracellulars

Publications (1)

Publication Number Publication Date
PL3351267T3 true PL3351267T3 (pl) 2020-11-30

Family

ID=41212183

Family Applications (2)

Application Number Title Priority Date Filing Date
PL09753743T PL2268308T3 (pl) 2008-04-18 2009-04-16 Szczepionka ochronna przeciwko lawsonia intracellularis
PL18154850T PL3351267T3 (pl) 2008-04-18 2009-04-16 Szczepionka ochronna przeciwko lawsonia intracellularis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL09753743T PL2268308T3 (pl) 2008-04-18 2009-04-16 Szczepionka ochronna przeciwko lawsonia intracellularis

Country Status (13)

Country Link
US (3) US20110033496A1 (pl)
EP (3) EP2268308B2 (pl)
JP (2) JP6026106B2 (pl)
CN (1) CN102006883A (pl)
BR (1) BR122019000869B1 (pl)
CA (1) CA2717969C (pl)
DK (2) DK2268308T3 (pl)
ES (1) ES2666671T3 (pl)
FR (1) FR21C1002I1 (pl)
HU (2) HUE038294T2 (pl)
PL (2) PL2268308T3 (pl)
TW (1) TWI551295B (pl)
WO (1) WO2009144088A2 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI551295B (zh) * 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
US8530223B2 (en) 2009-11-09 2013-09-10 Intervet International B.V. Method to grow Lawsonia intracellularis bacteria in persistently infected McCoy cells
KR101837768B1 (ko) 2011-05-25 2018-03-12 건국대학교 산학협력단 돼지 증식성 회장염을 진단하기 위한 단백질 및 그 응용
ES2771899T3 (es) 2013-12-03 2020-07-07 Intervet Int Bv Vacuna contra circovirus porcino de tipo 2
JP6488304B2 (ja) 2013-12-03 2019-03-20 インターベット インターナショナル ベー． フェー． ローソニア・イントラセルラリス（ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）及びブタサーコウイルス（ｐｏｒｃｉｎｅ ｃｉｒｃｏｖｉｒｕｓ）２に対するワクチン
EP3076997B1 (en) * 2013-12-03 2018-08-29 Intervet International B.V. Swine vaccine against prrs and lawsonia intracellularis
ES2798282T3 (es) * 2015-02-04 2020-12-10 Intervet Int Bv Una vacuna para usar contra la infección asintomática por Lawsonia en un cerdo
US10751405B2 (en) * 2015-02-04 2020-08-25 Intervet Inc. Vaccine for use against subclinical Lawsonia infection in a pig
BR112018007918A2 (pt) * 2015-10-22 2018-10-30 Intervet Int Bv vacina, uso de antígeno de lawsonia intracellularis inativada, e, método para proteger um animal.
JP6655414B2 (ja) 2016-02-15 2020-02-26 株式会社デンソー 排気浄化システム
MX2020005584A (es) 2017-12-04 2020-09-14 Intervet Int Bv Vacunacion con particulas de replicon y adyuvante oleoso.
WO2019121513A1 (en) 2017-12-18 2019-06-27 Intervet International B.V. Swine influenza a virus vaccine
BR112020017520A2 (pt) 2018-02-28 2020-12-22 Boehringer Ingelheim Vetmedica Gmbh Método para redução de escatol e/ou indol em animais
BR112022025678A2 (pt) 2020-06-19 2023-01-17 Intervet Int Bv Vacina contra o vírus da influenza a suína compreendendo duas partículas de replicon de rna distintas
EP4168429A1 (en) 2020-06-19 2023-04-26 Intervet International B.V. Swine influenza a virus vaccine comprising a nucleic acid construct comprising first, second and third nucleic acid sequences encoding distinct neuraminidase antigens of the virus
CN115836082A (zh) 2020-06-19 2023-03-21 英特维特国际股份有限公司 包含编码特定病毒谱系抗原的核酸构建体的甲型猪流感病毒疫苗
US20230265130A1 (en) 2020-06-19 2023-08-24 Intervet Inc. Swine influenza a virus vaccine comprising a nucleic acid construct having a specific order of genes
US20250281597A1 (en) 2021-10-25 2025-09-11 Intervet Inc. A vaccine for the protection of piglets against swine influenza a virus infection
MX2024005116A (es) 2021-11-01 2024-05-16 Boehringer Ingelheim Vetmedica Gmbh Composiciones de gel inmunogenas.
WO2024068637A1 (en) 2022-09-27 2024-04-04 Intervet International B.V. A method of culturing lawsonia intracellularis bacteria
WO2024260953A1 (en) 2023-06-23 2024-12-26 Intervet International B.V. A method of culturing lawsonia intracellularis bacteria
WO2025262124A1 (en) 2024-06-19 2025-12-26 Intervet International B.V. Adjuvanted veterinary vaccines against enteric diseases
WO2025262123A1 (en) 2024-06-19 2025-12-26 Intervet International B.V. Veterinary vaccines against enteric diseases

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE115862T1 (de) 1989-02-04 1995-01-15 Akzo Nobel Nv Tocole als impfstoffadjuvans.
FR2649012B1 (fr) 1989-07-03 1991-10-25 Seppic Sa Emulsions multiphasiques injectables
US5885823A (en) 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
ATE329031T1 (de) * 1995-11-30 2006-06-15 Agriculture Victoria Serv Pty Therapeutische zusammensetzungen zur behandlung von lawsonia intracellularis infektionen
CA2372105A1 (en) * 1999-05-13 2000-11-23 Pfizer Products Inc. Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses
EP1094070A3 (en) 1999-10-22 2002-01-09 Pfizer Products Inc. Lawsonia intracellularis proteins, and related methods and materials
CA2423588A1 (en) 2000-09-29 2002-04-04 Arizona Board Of Regents On Behalf Of The University Of Arizona Improved vaccines for proliferative ileitis and methods of making and using the same
ES2360225T3 (es) 2000-12-20 2011-06-02 Intervet International Bv Vacuna contra lawsonia intracellularis.
KR101131845B1 (ko) 2003-07-25 2012-03-30 베링거잉겔하임베트메디카인코퍼레이티드 유럽 기원의 로소니아 인트라셀룰라리스, 및 이의 백신,진단제 및 사용 방법
CA2554472A1 (en) 2004-01-22 2005-08-04 Intervet International B.V. Lawsonia intracellularis subunit vaccines
KR20110132416A (ko) * 2004-04-05 2011-12-07 화이자 프로덕츠 인코포레이티드 미세유체화된 수중유 유화액 및 백신 조성물
NZ553776A (en) * 2004-09-22 2010-05-28 Glaxosmithkline Biolog Sa Immunogenic composition comprising staphylococcal PNAG and Type 5 and/or 8 Capsular polysaccharide or oligosaccharide.
US20070212373A1 (en) 2004-12-08 2007-09-13 Akzo Nobel N.V. Lawsonia Intracellularis 26 Kd Subunit Vaccine
US8834891B2 (en) * 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
KR101347503B1 (ko) 2005-09-09 2014-01-02 인터벳 인터내셔널 비.브이. Ｐｃｖ-2 백신
EP1991262A4 (en) 2006-03-03 2009-11-04 Merial Ltd MYCOPLASMA HYOPNEUMONIAE VACCINE
EP2476433A1 (en) * 2006-03-30 2012-07-18 GlaxoSmithKline Biologicals S.A. Immunogenic composition
PL2007419T3 (pl) 2006-04-10 2012-09-28 Intervet Int Bv Szczepionka przeciwko mykoplazmie i PRRSV
US8470336B2 (en) * 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
WO2007138036A1 (en) 2006-05-30 2007-12-06 Intervet International B.V. Vaccine against rickettsia-like organisms
TWI449533B (zh) 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
TWI551295B (zh) * 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
US10751405B2 (en) 2015-02-04 2020-08-25 Intervet Inc. Vaccine for use against subclinical Lawsonia infection in a pig

Also Published As

Publication number Publication date
EP3708186A1 (en) 2020-09-16
CA2717969A1 (en) 2009-12-03
US9198963B2 (en) 2015-12-01
DK2268308T3 (en) 2018-05-22
TW201002342A (en) 2010-01-16
US8597662B2 (en) 2013-12-03
US20130302372A1 (en) 2013-11-14
BRPI0909769A2 (pt) 2015-08-11
EP3351267B1 (en) 2020-08-05
HUE038294T2 (hu) 2018-10-29
WO2009144088A3 (en) 2010-05-06
EP2268308A2 (en) 2011-01-05
JP2011516600A (ja) 2011-05-26
EP2268308B2 (en) 2026-05-06
US20110033496A1 (en) 2011-02-10
CN102006883A (zh) 2011-04-06
ES2666671T3 (es) 2018-05-07
FR21C1002I1 (fr) 2021-03-05
BR122019000869B1 (pt) 2023-11-07
WO2009144088A2 (en) 2009-12-03
JP6138875B2 (ja) 2017-05-31
TWI551295B (zh) 2016-10-01
HUS2000047I1 (hu) 2020-12-28
JP6026106B2 (ja) 2016-11-16
PL2268308T3 (pl) 2018-07-31
EP2268308B1 (en) 2018-03-14
DK3351267T3 (da) 2020-09-21
CA2717969C (en) 2016-06-07
JP2016026154A (ja) 2016-02-12
US20130045228A1 (en) 2013-02-21
EP3351267A1 (en) 2018-07-25

Similar Documents

Publication Publication Date Title
HUS2000047I1 (hu) Vakcina Lawsonia intracellularis elleni védelemre
ZA200904923B (en) Vaccine
IL201782A0 (en) Vaccine
GB0717911D0 (en) Vaccine
GB0711858D0 (en) Vaccine
ZA201004303B (en) Vaccine
GB0810869D0 (en) Vaccine adjuvant composition
PT2187958T (pt) Vacina atenuada de erliquiose
ZA201103645B (en) Single-time vaccines
EP2252326A4 (en) VACCINE COMPOSITIONS
SI2272146T1 (sl) Zaščitna naprava
GB0805356D0 (en) Vaccine adjuvant composition
GB0710538D0 (en) Vaccine
GB0700135D0 (en) Vaccine
ZA201003851B (en) Vaccine
HUE051465T2 (hu) Vakcina Lawsonia intracellularis elleni védelemre
GB0801122D0 (en) Vaccine composition
GB0801278D0 (en) Protection device actuator
GB0709373D0 (en) BCG-based anti-atheroma vaccine
GB0820404D0 (en) Vaccine compositions
GB0702363D0 (en) Vaccine composition
IL204404A (en) Weakened fever vaccine
GB0802326D0 (en) Vaccine Composition
GB0725121D0 (en) Vaccine
GB0721928D0 (en) Vaccine